Back

Myocardial edema measured by T2 mapping is an independent predictor of ventricular arrhythmias in hypertrophic cardiomyopathy

28 August 2023 (09:15 - 09:50)
Organised by: Logo
Congress Presentation Part of: Risk stratification in hypertrophic left ventricle Myocardial Disease ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Yafim Brodov

Chaim Sheba Medical Center, Ramat Gan (Israel)

6 More presentations in this session

Presentation thumbnail
Anatomical, functional and prognostic correlates of resting coronary flow velocity in patients with hypertrophic cardiomyopathy
Doctor E. Palinkas (Szeged, HU)
Abstract Slides Video
Presentation thumbnail
Effects of treatment response on echocardiographic features among patients with light-chain cardiac amyloidosis
Assistant Professor A. Briasoulis (Athens, GR)
Abstract Slides
Presentation thumbnail
Identification of novel risk profiles for ventricular arrythmias in hypertrophic cardiomyopathy through clustering analysis including left ventricular strain data
Doctor A. Al wazzan (Rennes, FR)
Abstract Slides Video
Presentation thumbnail
Left Ventricular Global Longitudinal Strain (LV GLS) assessed by Echocardiography predicts myocardial fibrosis and iron overload in transfusion dependent beta-thalassemia patients
Doctor L. Fusini (Milan, IT)
Abstract Slides Video
Presentation thumbnail
The importance of vasodilator stress echocardiography in predicting all-cause mortality and acute heart failure in hypertrophic cardiomyopathy
Assistant Professor M. Tesic (Belgrade, RS)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification in hypertrophic left ventricle

The Event

Event poster

ESC Congress 2023

28 August 2023 09:15 CET
You may be interested in
thumbnail
Congress Session
Prognostication in left ventricular hypertrophy: role of cardiac magnetic resonance imaging
thumbnail
Congress Presentation
The prognostic and incremental value of T1 mapping for predicting adverse events in hypertrophic cardiomyopathy
thumbnail
Congress Session
Novel risk predictors in hypertrophic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources